
Topic
Metastatic Colorectal Cancer (mCRC)
17 Podcasts • 9 Cases on BackTable
Hear how experienced physicians manage Metastatic Colorectal Cancer (mCRC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 84 • 06 Oct 2026
Managing Refractory MSS-MCRC: Advanced Treatment Strategies
What options remain when a patient with microsatellite stable metastatic colorectal cancer (MSS mCRC) has progressed through every standard line of chemotherapy? On this episode of BackTable Tumor Board, Dr. Jun Gong is joined by Dr. Ibrahim Sahin and Dr. Sandra Algaze to explore the nuances of late-line management in MSS-mCRC. They discuss how to approach oxaliplatin retreatment and anti-EGFR rechallenge, the growing role of liquid biopsy and biomarker-driven selection, and the practicalities of DPYD testing after recent guideline changes.
More on Metastatic Colorectal Cancer (mCRC)
Loading recent podcasts…
Tumor Board # 84
Oct 5, 2026
with Dr. Ibrahim Sahin, Dr. Sandra Algaze, Dr. Jun Gong
What options remain when a patient with microsatellite stable metastatic colorectal cancer (MSS mCRC) has progressed...
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
1,800+ listens
Tumor Board # 55
Apr 13, 2026
with Dr. Shruti Patel, Dr. Jun Gong
How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco...
Tumor Board # 43
Jan 12, 2026
with Dr. Jun Gong, Dr. Jonathan Mizrahi
Get caught up on the cutting edge colorectal cancer trial data from ESMO 2025 with this 30-minute BackTable Tumor Board...
Tumor Board # 83
Sep 28, 2026
with Dr. Sandra Algaze, Dr. Ibrahim Sahin, Dr. Jun Gong
Which molecular alterations in colorectal cancer now change treatment and how quickly do you need the results to make...
Vascular & IR # 640
Apr 30, 2026
with Dr. Maarten Smits, Dr. Venkatesh Krishnasamy
When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In...
1,700+ listens
Vascular & IR # 621
Mar 1, 2026
with Dr. Jonas Redmond, Dr. Sabeen Dhand
With data increasingly positioning thermal ablation as a viable alternative to surgery for select liver metastases, the...
1,800+ listens
Vascular & IR # 561
Jul 28, 2025
with Dr. Tyler Sandow, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
When is Y90 the right treatment for metastatic disease? Join Drs. Tyler Sandow, Zach Berman and host Kavi Krishnasamy...
2,100+ listens
VI Case
Apr 30, 2026
with Dr. Maarten Smits and Dr. Venkatesh Krishnasamy
VI Case
Jun 23, 2025
with Dr. Tyler Sandow, Dr. Nima Kokabi and Dr. Venkatesh Krishnasamy
VI Case
Jul 7, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 7, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Apr 30, 2026
with Dr. Maarten Smits and Dr. Venkatesh Krishnasamy
VI Case
Jun 30, 2025
with Dr. Nima Kokabi, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy
VI Case
Jul 7, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 28, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.







